| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/02/2006 | EP1434766B1 Piperidine compounds as muscarinic antagonists |
| 08/02/2006 | EP1420815B1 Beta-amyloid-analogue - t-cell epitop vaccine |
| 08/02/2006 | EP1372737B1 Preparation for the prophylaxis of restenosis |
| 08/02/2006 | EP1358177B1 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 08/02/2006 | EP1341565B1 Drug delivery compositions and coated medical devices |
| 08/02/2006 | EP1333887B1 Combination therapy comprising anti-diabetic and anticonvulsant agents |
| 08/02/2006 | EP1330459B1 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 08/02/2006 | EP1296656B1 Method for preparing a composition |
| 08/02/2006 | EP1274421B1 Use of MEK-inhibitors for producing a medicament to treat negativstrang-RNA-viruses infections |
| 08/02/2006 | EP1267828B1 Pharmaceutical preparations containing saccharose fatty acid esters for controlling the release of active ingredients |
| 08/02/2006 | EP1265598B1 Pharmaceutical composition for application to mucosal surfaces |
| 08/02/2006 | EP1263418B1 Method of preparing cartilage enhancing food supplements |
| 08/02/2006 | EP1239791B1 Dental prosthesis with means for the release of active substances |
| 08/02/2006 | EP1196560B1 Neurotrophic factor receptor gfr-alpha-4 |
| 08/02/2006 | EP1165137B1 Sphingomyelin containing preparation for the enhancement of tumor therapy |
| 08/02/2006 | EP1058562B1 Compositions and methods of treating tumors |
| 08/02/2006 | EP1030662B1 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists |
| 08/02/2006 | EP1017397B1 Photosensitizer conjugates for pathogen targeting |
| 08/02/2006 | EP0866713B1 Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs |
| 08/02/2006 | CN1812973A Indazole compounds useful as protein kinase inhibitors |
| 08/02/2006 | CN1812814A Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| 08/02/2006 | CN1812812A Serum cholesterol lowering agnet or preventive or therapeutic agent for atherosclerosis |
| 08/02/2006 | CN1812792A Use of dipyridamole or mopidamole for treatment and prevention of thromboembolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptors |
| 08/02/2006 | CN1812780A Cancer treatment with epothilones |
| 08/02/2006 | CN1812777A Composition for lowering blood glucose |
| 08/02/2006 | CN1812776A Inhibition of protein kinase c-mu (pkd) as a treatment for cardiac hypertrophy and heart failure |
| 08/02/2006 | CN1267451C Somatostatin analogues |
| 08/02/2006 | CN1267446C Nucleoside derivatives as inhibitors of RNA-dependent PNA viral polymerase |
| 08/02/2006 | CN1267420C 药用活性哌啶衍生物 Pharmaceutically active piperidine derivatives |
| 08/02/2006 | CN1267148C Use of GnRH antagonists in prevention of diabetes by administration |
| 08/02/2006 | CN1267099C Medicament with protective effect against oxidative-toxic substances, particularly against cardiotoxin substances |
| 08/02/2006 | CN1267098C Usage of treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 08/02/2006 | CN1267088C Injection temp-sensing type implanting prepns. |
| 08/02/2006 | CN1267087C Pharmaceutical tablet |
| 08/02/2006 | CN1267016C Composition and method |
| 08/01/2006 | US7084267 for the regulation of telomerase RNA genes, including the Sp family of transcription factors |
| 08/01/2006 | US7084259 G-protein coupled receptors |
| 08/01/2006 | US7084166 Such as 1,1-di-(N-benzyl-indol-3-yl)-1-butene; for drug resistant tumors |
| 08/01/2006 | US7084161 Method for treating inflammatory diseases or conditions |
| 08/01/2006 | US7084160 2-Amino-(imidazole, thiazole, or oxazole) derivatives; tyrosine kinase, endothelial growth factor, angiogenesis and fibroblast growth factor inhibitors; anticarcinogenic and antidiabetic agents |
| 08/01/2006 | US7084141 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 08/01/2006 | US7084126 Methods and compositions for enhancing cellular function through protection of tissue components |
| 08/01/2006 | US7084122 Use of glycosides of mono- and diacyglycerol as anti-inflammatory agents |
| 08/01/2006 | US7084120 Prodrugs of DP IV-inhibitors |
| 08/01/2006 | US7084117 Anticancer/tumor/scarring agents |
| 08/01/2006 | US7084114 Mixtures of insulin drug-oligomer comprising polyalkylene glycol |
| 08/01/2006 | US7084109 FVIIa antagonists |
| 08/01/2006 | US7084107 Methods for stabilizing liquid nutritional products and products so stabilized |
| 08/01/2006 | US7083983 Inhibitors of the interaction between P53 and MDM2 |
| 08/01/2006 | US7083965 Polypeptides, polynucleotides; hybrids; culture product |
| 08/01/2006 | US7083947 Assay techniques using nematode worms |
| 08/01/2006 | US7083940 Polynucleotide encoding a polypeptide which has proteolytic activity for insulin like growth factor binding protein; use in diagnosis of fetal abnormalities |
| 08/01/2006 | US7083803 Ocular solutions |
| 08/01/2006 | US7083799 No-synthase inhibitors |
| 08/01/2006 | US7083798 Method of immunomodulatory treatment of insulin dependent diabetes mellitus using mycobacterial cell wall compositions |
| 08/01/2006 | US7083796 Fusion proteins of mycobacterium tuberculosis |
| 08/01/2006 | US7083787 Induce immunology response; administering yeast vehicle and antigen |
| 08/01/2006 | US7083777 Induce activation lymphocytes, cytokines; response to antigens; isolated polypeptide with carrier |
| 08/01/2006 | CA2375946C Pharmaceutical tablet and process for making thereof |
| 08/01/2006 | CA2375921C Goodpasture's syndrome model mouse |
| 08/01/2006 | CA2251194C Solid lipid compositions of lipophilic compounds for enhanced oral bioavailability |
| 07/27/2006 | WO2006079021A2 Use of sirtuin-activating compounds for treating flushing and drug induced weight gain |
| 07/27/2006 | WO2006078422A2 Methods for modulating tumor growth and metastasis |
| 07/27/2006 | WO2006077954A1 Remedy for neurological disease |
| 07/27/2006 | WO2006077846A1 Therapeutic agent for attention-deficit hyperactivity disorder |
| 07/27/2006 | WO2006077824A1 Drugs for nerve cell regeneration |
| 07/27/2006 | WO2006077793A1 Antitumor agent |
| 07/27/2006 | WO2006077724A1 Cancer vaccine preparation |
| 07/27/2006 | WO2006077592A2 Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts |
| 07/27/2006 | WO2006077427A2 Antiviral drug combinations |
| 07/27/2006 | WO2006076863A1 The synergistically pharmaceutical composition for inhibiting tumor |
| 07/27/2006 | WO2006076854A1 Combination medication for malignant tumors and application |
| 07/27/2006 | WO2006076844A1 Traditional chinese medicament for treating injuries from falls, rheumatism and ostealgia and method for manufacture thereof |
| 07/27/2006 | WO2006076797A1 Cathepsin k inhibitors and atherosclerosis |
| 07/27/2006 | WO2006037029A3 Methods for treating conditions associated with the accumulation of excess extracellular matrix |
| 07/27/2006 | WO2006020898A3 Methods of screening for inhibitors and compositions thereof for treating or preventing mycobacterium tuberculosis infection |
| 07/27/2006 | WO2005110483A3 Use of targeted oxidative therapeutic formulation in bone regeneration |
| 07/27/2006 | WO2005110480A3 Combination of organic compounds |
| 07/27/2006 | WO2005074898A3 Composition comprising (s) pantoprazole and an antibiotic for treating helicobacter pylori |
| 07/27/2006 | WO2004091517A3 Conjugates comprising human il-18 and substitution mutants thereof |
| 07/27/2006 | US20060167637 System and methods for optimized drug delivery and progression of diseased and normal cells |
| 07/27/2006 | US20060167101 Therapeutic use of D-methionine to reduce the toxicity of noise |
| 07/27/2006 | US20060167083 Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures |
| 07/27/2006 | US20060167074 Methods and compositions for the treatment of psychiatric disorders |
| 07/27/2006 | US20060167069 Pharmaceutical composition of metaxalone with enhanced oral bioavailability |
| 07/27/2006 | US20060167055 Non-nucleoside reverse transcriptase inhibitors |
| 07/27/2006 | US20060167045 Combination therapy using a dual ppar alpha/gamma agonist and an angiotensin II type I receptor antagonist |
| 07/27/2006 | US20060167042 antagonists of M3 muscarinic receptors; N-(1-Azabicyclo[2.2.2]oct-3-yl)-2-hydroxy-2,2-dithien-2-ylacetamide; respiratory disorders, urological disorders, gastrointestinal disorders, cardiovascular disorders; alkylation |
| 07/27/2006 | US20060167036 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 07/27/2006 | US20060167032 Pharmaceutical composition and method for treating disorders of the central nervous system |
| 07/27/2006 | US20060166976 Compositions and methods for treating or preventing convulsions or seizures |
| 07/27/2006 | US20060166970 Non-nucleosidic inhibitors of reverse transcriptase as antagonists of cell proliferation and inducers of cell differentiation |
| 07/27/2006 | US20060166959 Pharmaceutical compositions based on azetidine derivatives |
| 07/27/2006 | US20060166943 Microbicidal pyrimidine or triazine for preventing sexual hiv transmission |
| 07/27/2006 | US20060166941 Treatment and/or prevention of non-viral epithelial damage |
| 07/27/2006 | US20060166932 Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione |
| 07/27/2006 | US20060166903 Phosphocholine linked prodrug derivatives |
| 07/27/2006 | US20060166892 Treatment of cell proliferative disorders with chlorotoxin |
| 07/27/2006 | US20060166885 Treatment and prevention of decubitus |
| 07/27/2006 | US20060166872 Fp receptor antagonists or pgf2 alpha antagonists for treating menorrhagia |